230.36
price up icon10.59%   22.05
 
loading
전일 마감가:
$208.31
열려 있는:
$227.72
하루 거래량:
909.61K
Relative Volume:
1.92
시가총액:
$22.44B
수익:
$3.81B
순이익/손실:
$-644.79M
주가수익비율:
-36.92
EPS:
-6.24
순현금흐름:
$-669.77M
1주 성능:
-3.42%
1개월 성능:
-6.25%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
Value
$226.49
$234.80
1주일 범위
Value
$196.45
$235.03
52주 변동 폭
Value
$172.67
$287.88

Beigene Ltd Adr Stock (ONC) Company Profile

Name
명칭
Beigene Ltd Adr
Name
전화
13459494123
Name
주소
C/O MOURANT GOVERNANCE SERVICES (CAYMAN), GRAND CAYMAN
Name
직원
11,000
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
ONC's Discussions on Twitter

ONC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ONC
Beigene Ltd Adr
230.36 22.44B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.22 122.24B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
554.18 59.73B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
580.94 35.43B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
237.77 30.77B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
96.52 23.20B 3.30B -501.07M 1.03B -2.1146

Beigene Ltd Adr Stock (ONC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-07 개시 RBC Capital Mkts Outperform
2025-03-03 업그레이드 BofA Securities Neutral → Buy
2024-12-03 재개 Morgan Stanley Overweight
2024-09-18 개시 JMP Securities Mkt Outperform
2024-02-06 재개 JP Morgan Overweight
2023-09-12 개시 Macquarie Outperform
2023-08-17 개시 Jefferies Buy
2023-07-17 개시 Citigroup Buy
2023-06-30 다운그레이드 Bernstein Outperform → Mkt Perform
2023-01-12 개시 Daiwa Securities Buy
2022-10-13 업그레이드 Guggenheim Neutral → Buy
2022-10-13 업그레이드 SVB Leerink Mkt Perform → Outperform
2022-08-09 재개 JP Morgan Overweight
2022-03-17 다운그레이드 SVB Leerink Outperform → Mkt Perform
2022-02-07 개시 Deutsche Bank Buy
2021-10-12 개시 Bernstein Outperform
2021-10-06 업그레이드 CLSA Underperform → Buy
2021-03-08 개시 China Renaissance Buy
2021-03-01 다운그레이드 CLSA Outperform → Underperform
2020-11-09 다운그레이드 Ladenburg Thalmann Buy → Neutral
2020-11-06 다운그레이드 Maxim Group Buy → Hold
2020-11-06 다운그레이드 Piper Sandler Neutral → Underweight
모두보기

Beigene Ltd Adr 주식(ONC)의 최신 뉴스

pulisher
Apr 10, 2025

Permian Resources Corp [PR] Director makes an insider purchase of 250,000 shares worth 3.02 million. - knoxdaily.com

Apr 10, 2025
pulisher
Apr 07, 2025

RBC Capital sets BeiGene stock Outperform with $312 target By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

RBC Capital sets BeiGene stock Outperform with $312 target - Investing.com India

Apr 07, 2025
pulisher
Apr 04, 2025

JMP reiterates BeiGene stock with $348 target despite trial halt - Investing.com India

Apr 04, 2025
pulisher
Apr 03, 2025

Beigene’s president Wu Xiaobin sells $14.6 million in shares - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

BeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit - Benzinga

Apr 03, 2025
pulisher
Mar 31, 2025

Macquarie Prefers Biotechs Over CDMOs; Top Picks BEIGENE/ AKESO - AASTOCKS.com

Mar 31, 2025
pulisher
Mar 20, 2025

Beigene director Wang Xiaodong sells $10.9 million in shares By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Beigene director Wang Xiaodong sells $10.9 million in shares - Investing.com India

Mar 20, 2025
pulisher
Mar 18, 2025

Beigene’s Wu Xiaobin anticipates $1.06 million from RMB shares sale - Investing.com

Mar 18, 2025
pulisher
Mar 13, 2025

Bernstein raises BeiGene stock price target to $259 - Investing.com

Mar 13, 2025
pulisher
Mar 12, 2025

BeiGene CEO John Oyler sells $10 million in shares - Investing.com India

Mar 12, 2025
pulisher
Mar 08, 2025

Beigene CEO John Oyler sells $10.39 million in shares By Investing.com - Investing.com South Africa

Mar 08, 2025
pulisher
Mar 08, 2025

Beigene CEO John Oyler sells shares worth $14.6 million - Investing.com India

Mar 08, 2025
pulisher
Mar 08, 2025

BeiGene Stock: Top Executives Sell Shares Near Record High - Sharewise

Mar 08, 2025
pulisher
Mar 07, 2025

Beigene CEO John Oyler sells shares worth $14.6 million By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Beigene CEO John Oyler sells $10.39 million in shares - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

BeiGene Ltd. Sponsored ADR to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

Beigene chair Wang Xiaodong sells shares worth over $2 million - Investing.com India

Mar 06, 2025
pulisher
Mar 04, 2025

Beigene president sells economic interest in RMB shares for $1.16 million - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

BOCOMI: BEIGENE (06160.HK) Guides to Positive 2025 Operating Profit; Rating Kept at Buy - AASTOCKS.com

Mar 04, 2025
pulisher
Mar 03, 2025

JPMorgan maintains BeiGene stock Overweight rating, $311 target - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

Beigene SVP sells $331,375 in American depositary shares By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

Beigene SVP sells $331,375 in American depositary shares - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

JPMorgan maintains BeiGene stock Overweight rating, $311 target By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

BofA lifts BeiGene stock rating, raises target to $320 - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

BofA lifts BeiGene stock rating, raises target to $320 By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 01, 2025

Beigene directors Julian and Felix Baker sell $190m in shares - Investing.com India

Mar 01, 2025
pulisher
Feb 28, 2025

BeiGene gets FDA Orphan Drug Designation for sonrotocla - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Guggenheim lifts BeiGene stock target to $348, maintains Buy rating - Investing.com India

Feb 28, 2025
pulisher
Feb 28, 2025

Citizens JMP lifts BeiGene stock target to $348 on strong sales By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

Citizens JMP lifts BeiGene stock target to $348 on strong sales - Investing.com India

Feb 28, 2025
pulisher
Feb 27, 2025

AASTOCKS Financial NewsBeiGene, Ltd. (ONC) - AASTOCKS.com

Feb 27, 2025
pulisher
Feb 27, 2025

UBS Lifts BEIGENE (06160.HK) TP to $330, Rating Buy - AASTOCKS.com

Feb 27, 2025
pulisher
Feb 27, 2025

BeiGene stock price target raised to $334 at TD Cowen By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

BeiGene stock price target raised to $334 at TD Cowen - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

BeiGene stock target raised to $308 on strong FY results - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

BeiGene stock target raised to $308 on strong FY results By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

BeiGene beats Q4 expectations, sees strong 2025 revenue growth - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

BeiGene beats Q4 expectations, sees strong 2025 revenue growth By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 25, 2025

Beigene SVP sells shares worth $310,169 By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Beigene SVP sells shares worth $310,169 - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Beigene's global head of R&D sells $1.29m in shares - Investing.com

Feb 25, 2025
pulisher
Feb 24, 2025

Beigene, Ltd. (NASDAQ:ONC) COO Xiaobin Wu Sells 21,267 Shares - MarketBeat

Feb 24, 2025
pulisher
Feb 21, 2025

BeiGene stock soars to 52-week high of $258.66 amid robust growth - Investing.com India

Feb 21, 2025
pulisher
Feb 21, 2025

BeiGene stock soars to 52-week high of $258.66 amid robust growth By Investing.com - Investing.com South Africa

Feb 21, 2025

Beigene Ltd Adr (ONC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$96.52
price up icon 3.65%
$23.24
price up icon 15.33%
$237.77
price up icon 5.08%
$31.95
price up icon 2.37%
$68.57
price up icon 5.80%
자본화:     |  볼륨(24시간):